The present invention provides new pyridopyrazine compounds which are suitable for the treatment or prevention of physiological and/or pathophysiological states mediated and/or modulated by signal transduction pathways and/or enzymes in mammals and in particular in humans.
[EN] 4-PIPERIDINECARBOXAMIDE MODULATORS OF VANILLOID VR1 RECEPTOR<br/>[FR] MODULATEURS DE 4-PIPERIDINECARBOXAMIDE DU RECEPTEUR VANILLOIDE VR1
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2006058338A2
公开(公告)日:2006-06-01
[EN] This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals. [FR] Cette invention concerne des ligands du récepteur vanilloïde VR1. Plus particulièrement, l'invention concerne des amides isonipecotiques qui sont des modulateurs puissants convenant pour le traitement et la prévention de divers états pathologiques chez les mammifères.
I. Derivatives of Aminopyridines<sup>1</sup>
作者:Jack Bernstein、Barbara Stearns、Martin Dexter、W. A. Lott
DOI:10.1021/ja01197a047
日期:1947.5
4-Piperidinecarboxamide modulators of vanilloid VR1 receptor
申请人:Calvo R. Raul
公开号:US20060116368A1
公开(公告)日:2006-06-01
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.